Podcast: Play in new window | Download
Subscribe: RSS
In 2022, Dr. Jeff Rawson founded the Institute of Cannabis Science (ICS), a nonprofit organization that produces Honest Data About Weed. The mission of ICS is to conduct cannabis research that educates consumers, guides regulators to adopt testing regulations that are based on science, and ensures that products are safe for patients and consumers.
At CannMed 23 Dr. Rawson will participate in a panel discussion about Challenges with Regulating the Cannabis Industry as part of the CannMed Laboratory Compliance Testing Workshop.
In December 2022, he made a presentation entitled Misinformation in Cannabis Markets to the members of the Massachusetts (MA) Cannabis Advisory Board Research Subcommittee. Jeff has presented recommendations for corrective actions to prevent misinformation in the MA cannabis market. The Boston Globe has published his letters about the challenges of cannabis regulatory science.
During our conversation, we discuss:
- What the Institute of Cannabis Science is and what they do
- How the average THC% in Massachusetts flower increased from 2019 to 2022, and what could that be a sign of
- The information presented to consumers on dispensary websites is limited and vague
- The challenge of collecting and analyzing cannabis testing data
- How providing more information on cannabis labels leads to healthier consumers
Thanks to This Episode’s Sponsor: Brains Bioceutical
Brains Bioceutical is a global leader in EU-GMP-certified production of naturally-sourced active pharmaceutical ingredients for the pharmaceutical and nutraceutical industries. With a unique suite of licences, Brains Bioceutical is one of the only natural plant-based phytochemical API manufacturers in commercial production today, and is involved in academic and clinical trials across the globe. Brains Bioceutical is the leader in evidence-based Phyto-cannabinoid health solutions to enhance life and treatment options for all.
Learn more at brainsbioceutical.com
Additional Resources